Liposarcoma, Dedifferentiated
Information
- Disease name
- Liposarcoma, Dedifferentiated
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05218499 | Active, not recruiting | Phase 2/Phase 3 | Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma | March 25, 2022 | May 27, 2026 |
| NCT04794127 | Recruiting | Phase 2 | Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. | February 2, 2022 | February 2, 2025 |
| NCT05580588 | Recruiting | Phase 2 | Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas | August 31, 2023 | March 2025 |
| NCT06058793 | Recruiting | Phase 3 | Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma | December 12, 2023 | November 30, 2025 |
| NCT03989596 | Unknown status | Phase 2 | Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas | June 1, 2018 | December 31, 2022 |